The Magazine of Corporate Responsibility

Tag Archive for ‘Pharmaceutical Industry’

Drug Industry Lobbyists and Campaign Cash Stymie Bid to Restrain Medicare Prescription Costs

When Congress approved the landmark Medicare Part D program in 2003 to help seniors buy prescription drugs, it slapped on an unusual restriction: The federal government was barred from negotiating cheaper prices for those medicines. The ban on government price bargaining, justified by supporters on free market grounds, has been derided by critics as a giant gift to the drug industry.

Vying for Market Share, Companies Heavily Promote ‘Me Too’ Drugs

An investigation by ProPublica examines information from a database known as Open Payments, which gives the first comprehensive look at how much money drug and device companies have spent working with doctors. What it shows is that the drugs most aggressively promoted to doctors typically aren’t cures or even big medical breakthroughs. Some are top sellers, but most are not.

The Corporate Capture of the United States

Corporate governance activist Robert AG Monks argues that American corporations today are like the great European monarchies of long ago. “Corporations have effectively captured the United States: its judiciary, its political system, and its national wealth, without assuming any of the responsibilities of dominion,” he writes. “Evidence is everywhere.”